N-[3-(3-Amino-1H-indazol-4-ylethynyl)-phenyl]-4-(4-methyl-piperazin-1-yl)-3-trifluoromethyl-benzamide

ID: ALA4795268

Chembl Id: CHEMBL4795268

PubChem CID: 155386687

Max Phase: Preclinical

Molecular Formula: C28H25F3N6O

Molecular Weight: 518.54

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(c2ccc(C(=O)Nc3cccc(C#Cc4cccc5[nH]nc(N)c45)c3)cc2C(F)(F)F)CC1

Standard InChI:  InChI=1S/C28H25F3N6O/c1-36-12-14-37(15-13-36)24-11-10-20(17-22(24)28(29,30)31)27(38)33-21-6-2-4-18(16-21)8-9-19-5-3-7-23-25(19)26(32)35-34-23/h2-7,10-11,16-17H,12-15H2,1H3,(H,33,38)(H3,32,34,35)

Standard InChI Key:  PMKFHRVILXSTGE-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4795268

    ---

Associated Targets(Human)

ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L132 (227 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 518.54Molecular Weight (Monoisotopic): 518.2042AlogP: 4.57#Rotatable Bonds: 3
Polar Surface Area: 90.28Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.45CX LogP: 5.11CX LogD: 4.78
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.35Np Likeness Score: -1.52

References

1. El-Damasy AK,Jin H,Seo SH,Bang EK,Keum G.  (2020)  Design, synthesis, and biological evaluations of novel 3-amino-4-ethynyl indazole derivatives as Bcr-Abl kinase inhibitors with potent cellular antileukemic activity.,  207  [PMID:32961435] [10.1016/j.ejmech.2020.112710]

Source